ConductScience.org, home

Paper42979004PubMed

Antiviral effects of traditional herbal medicine Otsu-Ji-To against human coronavirus OC43, SARS-CoV-2, and its variants: in vitro and in vivo studies.

Jin YH and 9 others. J Tradit Complement Med, 2026.

Cite this record

ConductScience Library. Antiviral effects of traditional herbal medicine Otsu-Ji-To against human coronavirus OC43, SARS-CoV-2, and its variants: in vitro and in vivo studies. Papers, record 42979004. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42979004

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antiviral effects of traditional herbal medicine Otsu-Ji-To against human coronavirus OC43, SARS-CoV-2, and its variants: in vitro and in vivo studies.
Journal
J Tradit Complement Med
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-11-05

Source PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jin YHYoung-Hee
2Habib MMobashira
3Oh EYEun Young
4Park SSohyun
5Ha IJIn Jin
6Min JSJung Sun
7Yoon JJiwon
8Park HHyeonjeong
9Lee SMSang-Myeong
10Kwon SSunoh

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129385192Anti-influenza A virus activity of rhein through regulating oxidative stress, TLR4, Akt, MAPK, and NF-κB signal pathways.PLoS One2018https://conductscience.org/library/papers/29385192PubMed
223454684Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease.J Ethnopharmacol2013https://conductscience.org/library/papers/23454684PubMed
338097457Intranasal immunization with the recombinant measles virus encoding the spike protein of SARS-CoV-2 confers protective immunity against COVID-19 in hamsters.Vaccine2024https://conductscience.org/library/papers/38097457PubMed
410704056Inhibitory effect of ferulic acid and isoferulic acid on the production of macrophage inflammatory protein-2 in response to respiratory syncytial virus infection in RAW264.7 cells.Mediators Inflamm1999https://conductscience.org/library/papers/10704056PubMed
524397541Anti-hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species.Microbiol Immunol2014https://conductscience.org/library/papers/24397541PubMed
635971968Virtual screening reveals liquiritigenin as a broad-spectrum inhibitor of SARS-CoV-2 variants of concern: an in silico study.J Biomol Struct Dyn2023https://conductscience.org/library/papers/35971968PubMed
738854515Systematic Studies on the Anti-SARS-CoV-2 Mechanisms of Tea Polyphenol-Related Natural Products.ACS Omega2024https://conductscience.org/library/papers/38854515PubMed
816789928Antiviral effects of saikosaponins on human coronavirus 229E in vitro.Clin Exp Pharmacol Physiol2006https://conductscience.org/library/papers/16789928PubMed
919507280Water extract of Glycyrrhiza uralensis inhibited enterovirus 71 in a human foreskin fibroblast cell line.Am J Chin Med2009https://conductscience.org/library/papers/19507280PubMed
1037259914Preparing for the next viral threat with broad-spectrum antivirals.J Clin Invest2023https://conductscience.org/library/papers/37259914PubMed
1118036887In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex.J Clin Virol2008https://conductscience.org/library/papers/18036887PubMed
1219126557Evaluation of oxygen radical absorbance capacity in kampo medicine.Evid Based Complement Alternat Med2011https://conductscience.org/library/papers/19126557PubMed
1334440200SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System.Biomedicines2021https://conductscience.org/library/papers/34440200PubMed
1435600857Promising Role of Emodin as Therapeutics to Against Viral Infections.Front Pharmacol2022https://conductscience.org/library/papers/35600857PubMed
1536328482Pharmacokinetic Interactions of a Licorice Dietary Supplement with Cytochrome P450 Enzymes in Female Participants.Drug Metab Dispos2023https://conductscience.org/library/papers/36328482PubMed
1614531019Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species.Planta Med2003https://conductscience.org/library/papers/14531019PubMed
1726231448Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB.J Ethnopharmacol2015https://conductscience.org/library/papers/26231448PubMed
187617763Inhibitory effect of ferulic acid and isoferulic acid on murine interleukin-8 production in response to influenza virus infections in vitro and in vivo.Planta Med1995https://conductscience.org/library/papers/7617763PubMed
1941798067Uncovering the covalent inhibitors of SARS-CoV-2 Mpro in Tibetan edible herb Rhodiola crenulata and their synergistic anti-Mpro mechanism.J Pharm Anal2026https://conductscience.org/library/papers/41798067PubMed
2033242624Chemical profile of Cimicifuga heracleifolia Kom. And immunomodulatory effect of its representative bioavailable component, cimigenoside on Poly(I:C)-induced airway inflammation.J Ethnopharmacol2021https://conductscience.org/library/papers/33242624PubMed

See all 50 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42979004

GET https://conductscience.org/api/papers/v1/42979004/references?page=2